Cargando…

Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease

INTRODUCTION: We assessed the feasibility and cognitive effects of a ketogenic diet (KD) in participants with Alzheimer's disease. METHODS: The Ketogenic Diet Retention and Feasibility Trial featured a 3-month, medium-chain triglyceride–supplemented KD followed by a 1-month washout in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor, Matthew K., Sullivan, Debra K., Mahnken, Jonathan D., Burns, Jeffrey M., Swerdlow, Russell H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021549/ https://www.ncbi.nlm.nih.gov/pubmed/29955649 http://dx.doi.org/10.1016/j.trci.2017.11.002

Ejemplares similares

An Experimental Ketogenic Diet for Alzheimer Disease Was Nutritionally Dense and Rich in Vegetables and Avocado
por: Taylor, Matthew K, et al.
Publicado: (2019)

Dietary Neuroketotherapeutics for Alzheimer’s Disease: An Evidence Update and the Potential Role for Diet Quality
por: Taylor, Matthew K., et al.
Publicado: (2019)

High Glycemic Diet Is Related to Brain Amyloid Accumulation Over One Year in Preclinical Alzheimer's Disease
por: Taylor, Matthew K., et al.
Publicado: (2021)

Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer’s Disease
por: Taylor, Matthew K., et al.
Publicado: (2022)

NHANES 2011–2014 Reveals Cognition of US Older Adults may Benefit from Better Adaptation to the Mediterranean Diet
por: Taylor, Matthew K., et al.
Publicado: (2020)

The Ketogenic Diet in the Treatment of Post-concussion Syndrome—A Feasibility Study
por: Rippee, Michael A., et al.
Publicado: (2020)

Ketogenic Diet in Alzheimer’s Disease
por: Rusek, Marta, et al.
Publicado: (2019)

Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients
por: Wilkins, Heather M., et al.
Publicado: (2017)

Efficacy, feasibility and tolerability of ketogenic diet for the treatment of poor response to bariatric surgery
por: Vinciguerra, F., et al.
Publicado: (2023)

Feasibility, tolerability and efficacy of the ketogenic diet in children with drug‐resistant epilepsy in Vietnam
por: Nguyen, Thuy Minh Thu, et al.
Publicado: (2023)

Feasibility of Parent-to-Parent Support in Recently Diagnosed Childhood Diabetes: The PLUS Study
por: Channon, Sue, et al.
Publicado: (2016)

Rationale, Feasibility and Acceptability of Ketogenic Diet for Cancer Treatment
por: Chung, Hae-Yun, et al.
Publicado: (2017)

To treat or not to treat Alzheimer’s disease by the ketogenic diet? That is the question
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2019)

Efficacy and Safety of Ketone Supplementation or Ketogenic Diets for Alzheimer's Disease: A Mini Review
por: Lilamand, Matthieu, et al.
Publicado: (2022)

Effect of Self-efficacy Intervention on Quality of Life of Patients With Intestinal Stoma
por: Xu, Shujuan, et al.
Publicado: (2018)

Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease
por: Phillips, Matthew C. L., et al.
Publicado: (2021)

A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6‐month RCT
por: Fortier, Mélanie, et al.
Publicado: (2020)

Are ketogenic diets promising for Alzheimer’s disease? A translational review
por: Lilamand, Matthieu, et al.
Publicado: (2020)

Diet, psychosocial stress, and Alzheimer's disease–related neuroanatomy in female nonhuman primates
por: Frye, Brett M., et al.
Publicado: (2020)

Development of Written Materials for Participants in an Alzheimer's Disease and Related Dementias Screening Trial
por: Head, Katharine J, et al.
Publicado: (2022)

Body brain life: A randomized controlled trial of an online dementia risk reduction intervention in middle-aged adults at risk of Alzheimer's disease
por: Anstey, Kaarin J., et al.
Publicado: (2015)

Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial
por: Morris, Jill K., et al.
Publicado: (2017)

Nuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease model
por: Srinivasan, Mythily, et al.
Publicado: (2018)

The Current Status of the Ketogenic Diet in Psychiatry
por: Bostock, Emmanuelle C. S., et al.
Publicado: (2017)

Ketogenic Diet and Epilepsy
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2019)

Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)
por: Włodarek, Dariusz
Publicado: (2019)

The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease
por: Burfeind, Kevin G., et al.
Publicado: (2017)

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy
por: Landen, Jaren W., et al.
Publicado: (2017)

A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease
por: Lutz, Michael W., et al.
Publicado: (2016)

A Systematic Review and Meta-Analysis of Low-Residue Diet Versus Clear Liquid Diet: Which Is Better for Bowel Preparation Before Colonoscopy?
por: Wu, Rui, et al.
Publicado: (2021)

Alzheimer's drug-development pipeline: 2016
por: Cummings, Jeffrey, et al.
Publicado: (2016)

The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial
por: Burns, Daniel K., et al.
Publicado: (2019)

The Importance and Impact of Nurse Leader Engagement With State Nursing Workforce Centers: Lessons From the COVID-19 Pandemic
por: Chan, Garrett K., et al.
Publicado: (2021)

Ketogenic diets and Ketone suplementation: A strategy for therapeutic intervention
por: Saris, Christiaan G. J., et al.
Publicado: (2022)

The Efficacy of Ketogenic Diet in 60 Chinese Patients With Dravet Syndrome
por: Tian, Xiaojuan, et al.
Publicado: (2019)

Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial
por: Hoscheidt, Siobhan, et al.
Publicado: (2021)

A narrative review on the effects of a ketogenic diet on patients with Alzheimer's disease
por: Tabaie, Ethan Ali, et al.
Publicado: (2021)

Analysis of high‐risk pedigrees identifies 11 candidate variants for Alzheimer's disease
por: Teerlink, Craig C., et al.
Publicado: (2021)

Alzheimer's disease drug development pipeline: 2018
por: Cummings, Jeffrey, et al.
Publicado: (2018)

Frequency of Diet and Physical Activity Goal Attainment and Barriers Encountered Among Adults With Type 2 Diabetes During a Telephone Coaching Intervention
por: Swoboda, Christine M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rn435tsf9vfhmcaoohj62ckt6l